Page 110 - 《中国药房》2024年23期
P. 110

多学科协作诊疗持续药学监护系统在抗感染治疗患者中的应用
                                                                                                           Δ


                                           3
                           1
                                   2
                 1*
          谭 瑞 ,邹婷婷 ,孙 伟 ,彭礼波 ,苟静惠 (1.重庆医科大学附属巴南医院药剂科,重庆 401320;2.重庆医
                                                   4 #
          科大学附属巴南医院感染肝病科,重庆 401320;3.重庆医科大学附属巴南医院重症医学科,重庆 401320;
          4.重庆医科大学附属第三医院药剂科,重庆 401120)
          中图分类号  R95      文献标志码  A      文章编号  1001-0408(2024)23-2936-05
          DOI  10.6039/j.issn.1001-0408.2024.23.16

          摘   要  目的  探索多学科协作诊疗(MDT)持续药学监护系统在抗感染治疗患者中的应用效果。方法  本研究团队通过创新研
          发一套MDT持续药学监护系统,将其应用于因感染经MDT后的抗感染治疗病例,以此实现持续用药监护模式创新。采用回顾性
          分析方法,收集重庆医科大学附属巴南医院2021年1-10月重症医学科经传统抗感染MDT的150例患者为对照组,2022年1-10
          月重症医学科因抗感染治疗实行MDT持续药学监护系统管理的130例患者为干预组。比较两组患者一般资料、持续跟踪管理情
          况、抗感染治疗转归情况、药品不良反应发生情况、抗菌药物管理相关指标以及相关医务人员对临床药师药学服务的满意度。
          结果  两组患者一般资料比较,差异均无统计学意义(P>0.05)。干预组患者持续跟踪管理比例明显高于对照组(P<0.01);且两
          组持续跟踪管理发起人员、发起原因比较,差异均有统计学意义(P<0.05)。干预组抗感染治疗转归情况优于对照组,抗菌药物管
          理相关指标(总住院时间、抗菌药物使用时间、药品总费用、抗菌药物使用量)低于对照组,医务人员综合满意度高于对照组,差异
          均有统计学差异(P<0.05)。两组患者不良反应发生情况、抗菌药物费用差异均无统计学意义(P>0.05)。结论  本系统应用于经
          MDT后的抗感染治疗患者,可实现以临床药师为核心的持续多学科跟踪管理,有利于提高MDT团队随访效率,提升临床药师药
          学服务质量,改善治疗结局,促进临床合理使用抗菌药物。
          关键词  多学科协作诊疗;持续药学监护系统;药学服务;抗菌药物;跟踪管理;满意度

          Application  of  the  multi-disciplinary  treatment-based  continuous  pharmaceutical  care  system  in  patients
          undergoing anti-infection treatment
          TAN Rui ,ZOU Tingting ,SUN Wei ,PENG Libo ,GOU Jinghui (1.  Dept.  of  Pharmacy,  Banan  Hospital
                                            2
                                 1
                                                                       4
                  1
                                                         3
          Affiliated  to  Chongqing  Medical  University,  Chongqing  401320,  China;2.  Dept.  of  Infectious  Hepatology,
          Banan Hospital Affiliated to Chongqing Medical University, Chongqing 401320, China;3. Dept. of Critical Care
          Medicine,  Banan  Hospital Affiliated  to  Chongqing  Medical  University,  Chongqing  401320,  China;4.  Dept.  of
          Pharmacy, the Third Affiliated Hospital of Chongqing Medical University, Chongqing 401120, China)
          ABSTRACT    OBJECTIVE  To  explore  the  application  effects  of  the  multi-disciplinary  treatment (MDT)-based  continuous
          pharmaceutical  care  system  in  patients  undergoing  anti-infection  treatment.  METHODS  This  research  team  innovatively  developed
          an  MDT  continuous  pharmaceutical  care  system,  which  was  applied  to  cases  of  anti-infection  treatment  following  MDT  due  to
          infection, aiming to innovate the continuous medication supervision model. A retrospective analysis method was used to collect data
          from 150 patients in the intensive care unit who underwent conventional anti-infection MDT consultations from January to October
          2021 in Banan Hospital Affiliated to Chongqing Medical University, serving as the control group, and 130 patients in the intensive
          care  unit  who  were  under  the  MDT  continuous  pharmaceutical  care  system  from  January  to  October  2022  were  selected  as  the
          intervention group. The general information of the patients, the information continuous tracking management, the outcomes of anti-
          infection  treatment,  adverse  drug  reactions,  antibacterial  drug  management  indicators,  and  the  degree  of  satisfaction  of  relevant
          medical staff with the clinical pharmacists’ pharmaceutical services were compared between the two groups. RESULTS Comparison
          of  general  information  between  the  two  groups  showed  no  statistically  significant  differences (P>0.05).  The  proportion  of
          continuous  tracking  management  in  the  intervention  group  was  significantly  higher  than  in  the  control  group (P<0.01),  and  the
          differences  in  the  initiators  and  reasons  for  continuous  tracking  management  between  the  two  groups  were  statistically  significant
         (P<0.05).  The  intervention  group  had  better  outcomes  in  anti-infection  treatment  compared  to  the  control  group (P<0.05).  The
                                                              antibacterial  drug  management  indicators  (total  length  of
              Δ 基金项目 重庆市科卫联合医学科研项目(No.2022QNXM003)
             * 第一作者 主 管 药 师 ,硕 士 。 研 究 方 向 :抗 感 染 。 E-mail:   hospital  stay,  duration  of  antibacterial  drug  use,  total  drug
          ruirui0615@163.com                                  costs,  and  amount  of  antibacterial  drugs  used)  in  the
              #  通信作者 主 管 药 师 ,硕 士 。 研 究 方 向 :抗 感 染 。 E-mail:  intervention  group  were  significantly  lower  than  in  the  control
          543207553@qq.com                                    group,  while  overall  degree  of  satisfaction  among  medical


          · 2936 ·    China Pharmacy  2024 Vol. 35  No. 23                            中国药房  2024年第35卷第23期
   105   106   107   108   109   110   111   112   113   114   115